{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:51:26Z","timestamp":1790621486704,"version":"4.1.0"},"reference-count":203,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province, China","doi-asserted-by":"crossref","award":["No. 17JR5RA272; No. 22JR5RA923"],"award-info":[{"award-number":["No. 17JR5RA272; No. 22JR5RA923"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Research Fund project of The First Hospital of Lanzhou University","award":["No. Ldyyyn2021-120; No. Ldyyyn2020-98; No. Ldyyyn2021-30"],"award-info":[{"award-number":["No. Ldyyyn2021-120; No. Ldyyyn2020-98; No. Ldyyyn2021-30"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-025-02470-z","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T02:10:09Z","timestamp":1759889409000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Exosome-mediated metabolic reprogramming: effects on thyroid cancer progression and tumor microenvironment remodeling"],"prefix":"10.1186","volume":"24","author":[{"given":"Shouhua","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengtong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaili","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-xun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"issue":"2","key":"2470_CR1","first-page":"1579","volume":"18","author":"SS Wen","year":"2019","unstructured":"Wen SS, et al. Metabolic reprogramming and its clinical application in thyroid cancer. Oncol Lett. 2019;18(2):1579\u201384.","journal-title":"Oncol Lett"},{"key":"2470_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113702","volume":"144","author":"S Li","year":"2025","unstructured":"Li S, et al. Emerging role of metabolic reprogramming in the immune microenvironment and immunotherapy of thyroid cancer. Int Immunopharmacol. 2025;144:113702.","journal-title":"Int Immunopharmacol"},{"key":"2470_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13578-019-0282-2","volume":"9","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, et al. Exosomes: biogenesis, biologic function and clinical potential. Cell Biosci. 2019;9:19.","journal-title":"Cell Biosci"},{"key":"2470_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241210267","author":"M Nowak","year":"2023","unstructured":"Nowak M, et al. Extracellular vesicles as drug transporters. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241210267.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"2470_CR5","doi-asserted-by":"publisher","first-page":"17802","DOI":"10.1021\/acsnano.2c08774","volume":"16","author":"R Tenchov","year":"2022","unstructured":"Tenchov R, et al. ExosomesNature\u2019s lipid nanoparticles, a rising star in drug delivery and diagnostics. ACS Nano. 2022;16(11):17802\u201346.","journal-title":"ACS Nano"},{"issue":"1","key":"2470_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00359-5","volume":"5","author":"E Yang","year":"2020","unstructured":"Yang E, et al. Exosome-mediated metabolic reprogramming: the emerging role in tumor microenvironment remodeling and its influence on cancer progression. Signal Transduct Target Ther. 2020;5(1):242.","journal-title":"Signal Transduct Target Ther"},{"issue":"10387","key":"2470_CR7","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S0140-6736(23)00020-X","volume":"401","author":"DW Chen","year":"2023","unstructured":"Chen DW, et al. Thyroid cancer. Lancet. 2023;401(10387):1531\u201344.","journal-title":"Lancet"},{"issue":"4","key":"2470_CR8","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S2213-8587(21)00027-9","volume":"9","author":"A Miranda-Filho","year":"2021","unstructured":"Miranda-Filho A, et al. Thyroid cancer incidence trends by histology in 25 countries: a population-based study. Lancet Diabetes Endocrinol. 2021;9(4):225\u201334.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"2470_CR9","first-page":"437","volume":"133","author":"AC Yu","year":"2023","unstructured":"Yu AC, et al. Anaplastic Transformation Differentiated Thyroid Carcinoma. 2023;133(2):437\u201342.","journal-title":"Anaplastic Transformation Differentiated Thyroid Carcinoma"},{"issue":"5","key":"2470_CR10","first-page":"425","volume":"331","author":"L Boucai","year":"2024","unstructured":"Boucai L, Zafereo M, Cabanillas ME. Thyroid Cancer: Rev Jama. 2024;331(5):425\u201335.","journal-title":"Thyroid Cancer: Rev Jama"},{"issue":"20","key":"2470_CR11","doi-asserted-by":"publisher","first-page":"5012","DOI":"10.1158\/1078-0432.CCR-16-0484","volume":"22","author":"F Raue","year":"2016","unstructured":"Raue F, Frank-Raue K. Thyroid cancer: risk-stratified management and individualized therapy. Clin Cancer Res. 2016;22(20):5012\u201321.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"2470_CR12","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3803\/EnM.2023.1802","volume":"39","author":"SH Ju","year":"2024","unstructured":"Ju SH, et al. Metabolic reprogramming in thyroid cancer. Endocrinol Metabolism. 2024;39(3):425\u201344.","journal-title":"Endocrinol Metabolism"},{"issue":"1","key":"2470_CR13","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12943-025-02263-4","volume":"24","author":"Y Wan","year":"2025","unstructured":"Wan Y, et al. Reprogramming of thyroid cancer metabolism: from mechanism to therapeutic strategy. Mol Cancer. 2025;24(1):74.","journal-title":"Mol Cancer"},{"issue":"1","key":"2470_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04617-2","volume":"21","author":"SL Duan","year":"2023","unstructured":"Duan SL, et al. The potential role of reprogrammed glucose metabolism: an emerging actionable codependent target in thyroid cancer. J Transl Med. 2023;21(1):735.","journal-title":"J Transl Med"},{"issue":"3","key":"2470_CR15","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","volume":"41","author":"MV Liberti","year":"2016","unstructured":"Liberti MV, Locasale JW. The warburg effect: how does it benefit cancer cells?? Trends Biochem Sci. 2016;41(3):211\u20138.","journal-title":"Trends Biochem Sci"},{"issue":"1","key":"2470_CR16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12964-020-00586-x","volume":"18","author":"S Heydarzadeh","year":"2020","unstructured":"Heydarzadeh S, et al. Regulators of glucose uptake in thyroid cancer cell lines. Cell Commun Signal. 2020;18(1):83.","journal-title":"Cell Commun Signal"},{"issue":"3","key":"2470_CR17","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3892\/mmr.2012.969","volume":"6","author":"P J\u00f3\u017awiak","year":"2012","unstructured":"J\u00f3\u017awiak P, et al. Expression of hypoxia-related glucose transporters GLUT1 and GLUT3 in benign, malignant and non-neoplastic thyroid lesions. Mol Med Rep. 2012;6(3):601\u20136.","journal-title":"Mol Med Rep"},{"key":"2470_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02263-4","author":"YX Wan","year":"2025","unstructured":"Wan YX, et al. Reprogramming of thyroid cancer metabolism: from mechanism to therapeutic strategy. Mol Cancer. 2025. https:\/\/doi.org\/10.1186\/s12943-025-02263-4.","journal-title":"Mol Cancer"},{"key":"2470_CR19","doi-asserted-by":"publisher","first-page":"144681","DOI":"10.1016\/j.gene.2020.144681","volume":"750","author":"J Huang","year":"2020","unstructured":"Huang J, et al. Up-regulated ANP32E promotes the thyroid carcinoma cell proliferation and migration via activating AKT\/mTOR\/HK2-mediated glycolysis. Gene. 2020;750:144681.","journal-title":"Gene"},{"issue":"9","key":"2470_CR20","doi-asserted-by":"publisher","first-page":"E1524","DOI":"10.1210\/jc.2012-4258","volume":"98","author":"C Feng","year":"2013","unstructured":"Feng C, et al. Aberrant overexpression of pyruvate kinase M2 is associated with aggressive tumor features and the BRAF mutation in papillary thyroid cancer. J Clin Endocrinol Metab. 2013;98(9):E1524\u201333.","journal-title":"J Clin Endocrinol Metab"},{"key":"2470_CR21","doi-asserted-by":"publisher","first-page":"7629","DOI":"10.2147\/OTT.S253137","volume":"13","author":"B Liu","year":"2020","unstructured":"Liu B, et al. Phosphoribosyl pyrophosphate amidotransferase promotes the progression of thyroid cancer via regulating pyruvate kinase M2. Onco Targets Ther. 2020;13:7629\u201339.","journal-title":"Onco Targets Ther"},{"issue":"10","key":"2470_CR22","doi-asserted-by":"publisher","first-page":"4814","DOI":"10.1111\/jcmm.16453","volume":"25","author":"JM Wang","year":"2021","unstructured":"Wang JM, et al. HYOU1 facilitates proliferation, invasion and glycolysis of papillary thyroid cancer via stabilizing LDHB mRNA. J Cell Mol Med. 2021;25(10):4814\u201325.","journal-title":"J Cell Mol Med"},{"key":"2470_CR23","doi-asserted-by":"crossref","unstructured":"Rossi ED et al. The expression of monocarboxylate transporters in thyroid carcinoma can be associated with the morphological features of <\u2009i\u2009> BRAF <\u2009i><sup\u2009>\u2009V600E\u2009mutation<\/sup\u2009>. Endocrine, 2017. 56(2): pp. 379\u2013387.","DOI":"10.1007\/s12020-016-1044-0"},{"issue":"6","key":"2470_CR24","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1097\/XCS.0000000000000226","volume":"234","author":"B Zhao","year":"2022","unstructured":"Zhao B, et al. Effect of lactate export inhibition on anaplastic thyroid cancer growth and metabolism. J Am Coll Surg. 2022;234(6):1044\u201350.","journal-title":"J Am Coll Surg"},{"issue":"9","key":"2470_CR25","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.tcb.2022.02.003","volume":"32","author":"X Bian","year":"2022","unstructured":"Bian X, et al. Regulation of gene expression by glycolytic and gluconeogenic enzymes. Trends Cell Biol. 2022;32(9):786\u201399.","journal-title":"Trends Cell Biol"},{"key":"2470_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25137129","author":"M Lukasiewicz","year":"2024","unstructured":"Lukasiewicz M, et al. The role of lipid metabolism disorders in the development of thyroid cancer. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25137129.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"2470_CR27","doi-asserted-by":"publisher","first-page":"4088","DOI":"10.1210\/jc.2008-0503","volume":"93","author":"S Uddin","year":"2008","unstructured":"Uddin S, et al. Fatty acid synthase and AKT pathway signaling in a subset of papillary thyroid cancers. J Clin Endocrinol Metab. 2008;93(10):4088\u201397.","journal-title":"J Clin Endocrinol Metab"},{"key":"2470_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217069","volume":"598","author":"J Chu","year":"2024","unstructured":"Chu J, et al. CircPCNXL2 promotes papillary thyroid carcinoma progression by regulating fatty acid metabolism induced by anabolic enzyme ACC1. Cancer Lett. 2024;598:217069.","journal-title":"Cancer Lett"},{"issue":"1","key":"2470_CR29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s12020-022-03124-6","volume":"78","author":"SS Huang","year":"2022","unstructured":"Huang SS, et al. ACLY inhibitors induce apoptosis and potentiate cytotoxic effects of Sorafenib in thyroid cancer cells. Endocrine. 2022;78(1):85\u201394.","journal-title":"Endocrine"},{"issue":"1","key":"2470_CR30","doi-asserted-by":"publisher","first-page":"10260","DOI":"10.1038\/s41598-019-46727-2","volume":"9","author":"G Revilla","year":"2019","unstructured":"Revilla G, et al. Cholesterol and 27-hydroxycholesterol promote thyroid carcinoma aggressiveness. Sci Rep. 2019;9(1):10260.","journal-title":"Sci Rep"},{"issue":"1","key":"2470_CR31","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s12920-024-01975-8","volume":"17","author":"M Li","year":"2024","unstructured":"Li M, et al. Biomarkers related to m6A and succinic acid metabolism in papillary thyroid carcinoma. BMC Med Genomics. 2024;17(1):199.","journal-title":"BMC Med Genomics"},{"issue":"2","key":"2470_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.22168","volume":"85","author":"Z Liang","year":"2024","unstructured":"Liang Z, et al. Hypoxia expedites the progression of papillary thyroid carcinoma by promoting the CPT1A-mediated fatty acid oxidative pathway. Drug Dev Res. 2024;85(2):e22168.","journal-title":"Drug Dev Res"},{"key":"2470_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109791","volume":"123","author":"C Li","year":"2020","unstructured":"Li C, et al. SREBP1 as a potential biomarker predicts levothyroxine efficacy of differentiated thyroid cancer. Biomed Pharmacother. 2020;123:109791.","journal-title":"Biomed Pharmacother"},{"key":"2470_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115907","volume":"218","author":"J Lu","year":"2023","unstructured":"Lu J, et al. Targeting cholesterol metabolism in cancer: from molecular mechanisms to therapeutic implications. Biochem Pharmacol. 2023;218:115907.","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"2470_CR35","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.7150\/thno.82920","volume":"13","author":"K Yang","year":"2023","unstructured":"Yang K, et al. The role of lipid metabolic reprogramming in tumor microenvironment. Theranostics. 2023;13(6):1774\u2013808.","journal-title":"Theranostics"},{"issue":"1","key":"2470_CR36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s12276-020-0375-3","volume":"52","author":"EL Lieu","year":"2020","unstructured":"Lieu EL, et al. Amino acids in cancer. Exp Mol Med. 2020;52(1):15\u201330.","journal-title":"Exp Mol Med"},{"issue":"1","key":"2470_CR37","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s13046-018-0907-z","volume":"37","author":"P H\u00e4fliger","year":"2018","unstructured":"H\u00e4fliger P, et al. The LAT1 inhibitor JPH203 reduces growth of thyroid carcinoma in a fully immunocompetent mouse model. J Exp Clin Cancer Res. 2018;37(1):234.","journal-title":"J Exp Clin Cancer Res"},{"issue":"33","key":"2470_CR38","doi-asserted-by":"publisher","first-page":"53628","DOI":"10.18632\/oncotarget.10682","volume":"7","author":"HM Kim","year":"2016","unstructured":"Kim HM, Lee YK, Koo JS. Expression of glutamine metabolism-related proteins in thyroid cancer. Oncotarget. 2016;7(33):53628\u201341.","journal-title":"Oncotarget"},{"issue":"7","key":"2470_CR39","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41419-023-05981-z","volume":"14","author":"X Li","year":"2023","unstructured":"Li X, et al. Stag2 inactivation reprograms glutamine metabolism of BRAF-mutant thyroid cancer cells. Cell Death Dis. 2023;14(7):454.","journal-title":"Cell Death Dis"},{"key":"2470_CR40","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.2147\/OTT.S189536","volume":"12","author":"Z Chen","year":"2019","unstructured":"Chen Z, et al. SIRT4 inhibits the proliferation, migration, and invasion abilities of thyroid cancer cells by inhibiting glutamine metabolism. Onco Targets Ther. 2019;12:2397\u2013408.","journal-title":"Onco Targets Ther"},{"key":"2470_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-016-0915-8","author":"WY Sun","year":"2016","unstructured":"Sun WY, et al. Expression of serine\/glycine metabolism-related proteins is different according to the thyroid cancer subtype. J Transl Med. 2016. https:\/\/doi.org\/10.1186\/s12967-016-0915-8.","journal-title":"J Transl Med"},{"issue":"11","key":"2470_CR42","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1089\/thy.2020.0105","volume":"30","author":"MJ Jeon","year":"2020","unstructured":"Jeon MJ, et al. High phosphoglycerate dehydrogenase expression induces stemness and aggressiveness in thyroid cancer. Thyroid. 2020;30(11):1625\u201338.","journal-title":"Thyroid"},{"issue":"8","key":"2470_CR43","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41419-023-06041-2","volume":"14","author":"Y Hwang","year":"2023","unstructured":"Hwang Y, et al. Co-inhibition of glutaminolysis and one-carbon metabolism promotes ROS accumulation leading to enhancement of chemotherapeutic efficacy in anaplastic thyroid cancer. Cell Death Dis. 2023;14(8):515.","journal-title":"Cell Death Dis"},{"issue":"1","key":"2470_CR44","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41419-024-06476-1","volume":"15","author":"M Sun","year":"2024","unstructured":"Sun M, et al. SHMT2 promotes papillary thyroid cancer metastasis through epigenetic activation of AKT signaling. Cell Death Dis. 2024;15(1):87.","journal-title":"Cell Death Dis"},{"issue":"5","key":"2470_CR45","doi-asserted-by":"publisher","first-page":"E832","DOI":"10.1210\/jc.2013-3351","volume":"99","author":"S Moretti","year":"2014","unstructured":"Moretti S, et al. Indoleamine 2,3-dioxygenase 1 (IDO1) is up-regulated in thyroid carcinoma and drives the development of an immunosuppressant tumor microenvironment. J Clin Endocrinol Metab. 2014;99(5):E832\u201340.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2470_CR46","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1186\/s12967-024-05651-4","volume":"22","author":"Z Li","year":"2024","unstructured":"Li Z, et al. Potential functions and mechanisms of lysine crotonylation modification (Kcr) in tumorigenesis and lymphatic metastasis of papillary thyroid cancer (PTC). J Transl Med. 2024;22(1):874.","journal-title":"J Transl Med"},{"issue":"1","key":"2470_CR47","doi-asserted-by":"publisher","first-page":"19396","DOI":"10.1038\/s41598-022-23906-2","volume":"12","author":"KR Sekhar","year":"2022","unstructured":"Sekhar KR, et al. Glutathione peroxidase 4 inhibition induces ferroptosis and mTOR pathway suppression in thyroid cancer. Sci Rep. 2022;12(1):19396.","journal-title":"Sci Rep"},{"key":"2470_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21020665","author":"YW Yi","year":"2020","unstructured":"Yi YW, et al. Advances in analysis of biodistribution of exosomes by molecular imaging. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21020665.","journal-title":"Int J Mol Sci"},{"key":"2470_CR49","doi-asserted-by":"publisher","DOI":"10.3402\/jev.v4.27066","volume":"4","author":"M Y\u00e1\u00f1ez-M\u00f3","year":"2015","unstructured":"Y\u00e1\u00f1ez-M\u00f3 M, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015;4:27066.","journal-title":"J Extracell Vesicles"},{"issue":"7578","key":"2470_CR50","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nature15756","volume":"527","author":"A Hoshino","year":"2015","unstructured":"Hoshino A, et al. Tumour exosome integrins determine organotropic metastasis. Nature. 2015;527(7578):329\u201335.","journal-title":"Nature"},{"key":"2470_CR51","doi-asserted-by":"publisher","DOI":"10.3402\/jev.v3.24641","author":"LA Mulcahy","year":"2014","unstructured":"Mulcahy LA, Pink RC, Carter DR. Routes and mechanisms of extracellular vesicle uptake. J Extracell Vesicles. 2014. https:\/\/doi.org\/10.3402\/jev.v3.24641.","journal-title":"J Extracell Vesicles"},{"issue":"6","key":"2470_CR52","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3109\/10409238.2010.502516","volume":"45","author":"JH Hurley","year":"2010","unstructured":"Hurley JH. The ESCRT complexes. Crit Rev Biochem Mol Biol. 2010;45(6):463\u201387.","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"1","key":"2470_CR53","doi-asserted-by":"publisher","first-page":"237","DOI":"10.7150\/thno.21945","volume":"8","author":"C He","year":"2018","unstructured":"He C, et al. Exosome theranostics: biology and translational medicine. Theranostics. 2018;8(1):237\u201355.","journal-title":"Theranostics"},{"issue":"1","key":"2470_CR54","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12964-021-00730-1","volume":"19","author":"S Gurung","year":"2021","unstructured":"Gurung S, et al. The exosome journey: from biogenesis to uptake and intracellular signalling. Cell Commun Signal. 2021;19(1):47.","journal-title":"Cell Commun Signal"},{"issue":"9","key":"2470_CR55","first-page":"1390","volume":"54","author":"XY Wang","year":"2022","unstructured":"Wang XY, et al. The updated role of Exosomal proteins in the diagnosis, prognosis, and treatment of cancer. Experimental Mol Med. 2022;54(9):1390\u2013400.","journal-title":"Experimental Mol Med"},{"key":"2470_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00383","volume":"5","author":"O Moreno-Gonzalo","year":"2014","unstructured":"Moreno-Gonzalo O, Villarroya-Beltri C, S\u00e1nchez-Madrid F. Post-translational modifications of exosomal proteins. Front Immunol. 2014;5:383.","journal-title":"Front Immunol"},{"issue":"3","key":"2470_CR57","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.4049\/jimmunol.0900798","volume":"183","author":"S Lynch","year":"2009","unstructured":"Lynch S, et al. Novel MHC class I structures on exosomes. J Immunol. 2009;183(3):1884\u201391.","journal-title":"J Immunol"},{"issue":"6","key":"2470_CR58","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/ajco.12869","volume":"14","author":"RR Malla","year":"2018","unstructured":"Malla RR, et al. Exosomal tetraspanins as regulators of cancer progression and metastasis and novel diagnostic markers. Asia Pac J Clin Oncol. 2018;14(6):383\u201391.","journal-title":"Asia Pac J Clin Oncol"},{"issue":"1","key":"2470_CR59","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1021\/acs.jproteome.6b00811","volume":"16","author":"S Chauhan","year":"2017","unstructured":"Chauhan S, et al. Surface glycoproteins of exosomes shed by Myeloid-Derived suppressor cells contribute to function. J Proteome Res. 2017;16(1):238\u201346.","journal-title":"J Proteome Res"},{"issue":"7","key":"2470_CR60","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.4161\/onci.20897","volume":"1","author":"S Munich","year":"2012","unstructured":"Munich S, et al. Dendritic cell exosomes directly kill tumor cells and activate natural killer cells via TNF superfamily ligands. Oncoimmunology. 2012;1(7):1074\u201383.","journal-title":"Oncoimmunology"},{"issue":"13","key":"2470_CR61","doi-asserted-by":"publisher","first-page":"3580","DOI":"10.1158\/1078-0432.CCR-11-3359","volume":"18","author":"CM Chan","year":"2012","unstructured":"Chan CM, et al. Targeted inhibition of Src kinase with dasatinib blocks thyroid cancer growth and metastasis. Clin Cancer Res. 2012;18(13):3580\u201391.","journal-title":"Clin Cancer Res"},{"issue":"10","key":"2470_CR62","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1530\/ERC-17-0547","volume":"25","author":"D Luo","year":"2018","unstructured":"Luo D, et al. Proteomics study of serum exosomes from papillary thyroid cancer patients. Endocr Relat Cancer. 2018;25(10):879\u201391.","journal-title":"Endocr Relat Cancer"},{"key":"2470_CR63","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2021.5284","author":"Q Li","year":"2021","unstructured":"Li Q, et al. Exosomal ANXA1 derived from thyroid cancer cells is associated with malignant transformation of human thyroid follicular epithelial cells by promoting cell proliferation. Int J Oncol. 2021. https:\/\/doi.org\/10.3892\/ijo.2021.5284.","journal-title":"Int J Oncol"},{"issue":"4","key":"2470_CR64","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1530\/ERC-14-0077","volume":"21","author":"M Boufraqech","year":"2014","unstructured":"Boufraqech M, et al. MiR-145 suppresses thyroid cancer growth and metastasis and targets AKT3. Endocr Relat Cancer. 2014;21(4):517\u201331.","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"2470_CR65","first-page":"8590","volume":"8","author":"Y Gu","year":"2015","unstructured":"Gu Y, et al. MicroRNA-145 inhibits human papillary cancer TPC1 cell proliferation by targeting DUSP6. Int J Clin Exp Med. 2015;8(6):8590\u20138.","journal-title":"Int J Clin Exp Med"},{"issue":"15","key":"2470_CR66","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1038\/onc.2011.381","volume":"31","author":"MV Geraldo","year":"2012","unstructured":"Geraldo MV, Yamashita AS, Kimura ET. Microrna miR-146b-5p regulates signal transduction of TGF-\u03b2 by repressing SMAD4 in thyroid cancer. Oncogene. 2012;31(15):1910\u201322.","journal-title":"Oncogene"},{"issue":"1","key":"2470_CR67","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1159\/000369676","volume":"35","author":"X Deng","year":"2015","unstructured":"Deng X, et al. MiR-146b-5p promotes metastasis and induces epithelial-mesenchymal transition in thyroid cancer by targeting ZNRF3. Cell Physiol Biochem. 2015;35(1):71\u201382.","journal-title":"Cell Physiol Biochem"},{"issue":"9","key":"2470_CR68","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1089\/thy.2017.0665","volume":"28","author":"Y Huang","year":"2018","unstructured":"Huang Y, et al. Microrna-222 promotes invasion and metastasis of papillary thyroid cancer through targeting protein phosphatase 2 regulatory subunit B alpha expression. Thyroid. 2018;28(9):1162\u201373.","journal-title":"Thyroid"},{"issue":"6","key":"2470_CR69","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1080\/15384047.2018.1433502","volume":"19","author":"J Liu","year":"2018","unstructured":"Liu J, et al. Effects of mir-144 on the sensitivity of human anaplastic thyroid carcinoma cells to cisplatin by autophagy regulation. Cancer Biol Ther. 2018;19(6):484\u201396.","journal-title":"Cancer Biol Ther"},{"issue":"2","key":"2470_CR70","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1007\/s12020-014-0326-7","volume":"48","author":"H Guan","year":"2015","unstructured":"Guan H, et al. Down-regulation of miR-144 promotes thyroid cancer cell invasion by targeting ZEB1 and ZEB2. Endocrine. 2015;48(2):566\u201374.","journal-title":"Endocrine"},{"issue":"5","key":"2470_CR71","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1159\/000494786","volume":"50","author":"F Xia","year":"2018","unstructured":"Xia F, et al. Long noncoding RNA HOXA-AS2 promotes papillary thyroid cancer progression by regulating miR-520c-3p\/S100A4 pathway. Cell Physiol Biochem. 2018;50(5):1659\u201372.","journal-title":"Cell Physiol Biochem"},{"issue":"9","key":"2470_CR72","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/s41419-020-02827-w","volume":"11","author":"W Dai","year":"2020","unstructured":"Dai W, et al. Exosomal lncRNA DOCK9-AS2 derived from cancer stem cell-like cells activated Wnt\/\u03b2-catenin pathway to aggravate stemness, proliferation, migration, and invasion in papillary thyroid carcinoma. Cell Death Dis. 2020;11(9):743.","journal-title":"Cell Death Dis"},{"key":"2470_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2022.153856","volume":"233","author":"Y Xu","year":"2022","unstructured":"Xu Y, et al. Long noncoding RNA GAS5 inhibits proliferation and metastasis in papillary thyroid carcinoma through the IFN\/STAT1 signaling pathway. Pathol Res Pract. 2022;233:153856.","journal-title":"Pathol Res Pract"},{"key":"2470_CR74","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.bbrc.2023.03.033","volume":"655","author":"M Yang","year":"2023","unstructured":"Yang M, et al. Novel LncRNA AK023507 inhibits cell metastasis and proliferation in papillary thyroid cancer through \u03b2-catenin\/Wnt signaling pathway. Biochem Biophys Res Commun. 2023;655:104\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"2470_CR75","first-page":"4361","volume":"24","author":"X Xiao","year":"2020","unstructured":"Xiao X, et al. LncRNA FALEC promotes proliferation, migration, and invasion of PTC cells through regulating Wnt\/\u03b2-catenin signaling pathway. Eur Rev Med Pharmacol Sci. 2020;24(8):4361\u20137.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"2470_CR76","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s13046-018-0936-7","volume":"37","author":"W Bi","year":"2018","unstructured":"Bi W, et al. CircRNA circrna_102171 promotes papillary thyroid cancer progression through modulating CTNNBIP1-dependent activation of \u03b2-catenin pathway. J Exp Clin Cancer Res. 2018;37(1):275.","journal-title":"J Exp Clin Cancer Res"},{"issue":"11","key":"2470_CR77","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1507\/endocrj.EJ20-0498","volume":"68","author":"H Zheng","year":"2021","unstructured":"Zheng H, et al. Circ_0079558 promotes papillary thyroid cancer progression by binding to miR-26b-5p to activate MET\/AKT signaling. Endocr J. 2021;68(11):1247\u201366.","journal-title":"Endocr J"},{"issue":"1","key":"2470_CR78","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1186\/s12967-024-05405-2","volume":"22","author":"JJ Li","year":"2024","unstructured":"Li JJ, et al. Circ_0004851 regulates the molecular mechanism of miR-296-3p\/FGF11 in the influence of high iodine on PTC. J Transl Med. 2024;22(1):586.","journal-title":"J Transl Med"},{"key":"2470_CR79","doi-asserted-by":"crossref","unstructured":"Wang HH, Ma JN, Zhan XR. Circular RNA Circ_0067934 Attenuates Ferroptosis of Thyroid Cancer Cells by miR-545-3p\/SLC7A11 Signaling. Front Endocrinol (Lausanne), 2021. 12: p. 670031.","DOI":"10.3389\/fendo.2021.670031"},{"key":"2470_CR80","doi-asserted-by":"publisher","first-page":"4667","DOI":"10.2147\/IJN.S458931","volume":"19","author":"CY Wang","year":"2024","unstructured":"Wang CY, et al. Long-Term changes of urinary Exosomal peptide levels after thyroidectomy in patients with thyroid cancer: A prospective observational study. Int J Nanomed. 2024;19:4667\u201377.","journal-title":"Int J Nanomed"},{"issue":"5","key":"2470_CR81","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.1002\/jcp.27486","volume":"234","author":"K Saliminejad","year":"2019","unstructured":"Saliminejad K, et al. An overview of microRNAs: biology, functions, therapeutics, and analysis methods. J Cell Physiol. 2019;234(5):5451\u201365.","journal-title":"J Cell Physiol"},{"key":"2470_CR82","doi-asserted-by":"publisher","unstructured":"Van Branteghem C, et al. Unraveling the roles of miR-204-5p and HMGA2 in papillary thyroid cancer tumorigenesis. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241310764.","DOI":"10.3390\/ijms241310764"},{"issue":"1","key":"2470_CR83","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13046-017-0504-6","volume":"36","author":"J Sun","year":"2017","unstructured":"Sun J, et al. E2f8, a direct target of miR-144, promotes papillary thyroid cancer progression via regulating cell cycle. J Exp Clin Cancer Res. 2017;36(1):40.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"2470_CR84","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-020-01570-6","volume":"39","author":"S Tan","year":"2020","unstructured":"Tan S, et al. Exosomal miRNAs in tumor microenvironment. J Exp Clin Cancer Res. 2020;39(1):67.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"2470_CR85","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41420-023-01514-x","volume":"9","author":"M De Martino","year":"2023","unstructured":"De Martino M, et al. The lncRNA RMST is drastically downregulated in anaplastic thyroid carcinomas where exerts a tumor suppressor activity impairing epithelial-mesenchymal transition and stemness. Cell Death Discov. 2023;9(1):216.","journal-title":"Cell Death Discov"},{"key":"2470_CR86","doi-asserted-by":"crossref","unstructured":"Zhang L et al. The important regulatory roles of circRNA\u2013encoded proteins or peptides in cancer pathogenesis (Review). Int J Oncol. 2024;64(2):19.","DOI":"10.3892\/ijo.2023.5607"},{"key":"2470_CR87","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15051465","author":"H Jo","year":"2023","unstructured":"Jo H, Shim K, Jeoung D. Exosomes: diagnostic and therapeutic implications in cancer. Pharmaceutics. 2023. https:\/\/doi.org\/10.3390\/pharmaceutics15051465.","journal-title":"Pharmaceutics"},{"issue":"1","key":"2470_CR88","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13046-023-02634-z","volume":"42","author":"S Tan","year":"2023","unstructured":"Tan S, et al. Exosomal cargos-mediated metabolic reprogramming in tumor microenvironment. J Exp Clin Cancer Res. 2023;42(1):59.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"2470_CR89","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00261-0","volume":"5","author":"J Dai","year":"2020","unstructured":"Dai J, et al. Exosomes: key players in cancer and potential therapeutic strategy. Signal Transduct Target Ther. 2020;5(1):145.","journal-title":"Signal Transduct Target Ther"},{"issue":"3191","key":"2470_CR90","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1126\/science.123.3191.309","volume":"123","author":"O Warburg","year":"1956","unstructured":"Warburg O. On the origin of cancer cells. Science. 1956;123(3191):309\u201314.","journal-title":"Science"},{"issue":"15","key":"2470_CR91","doi-asserted-by":"publisher","first-page":"3725","DOI":"10.1158\/1078-0432.CCR-16-0028","volume":"22","author":"AR Chin","year":"2016","unstructured":"Chin AR, Wang SE. Cancer tills the premetastatic field: mechanistic basis and clinical implications. Clin Cancer Res. 2016;22(15):3725\u201333.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"2470_CR92","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2021.12677","volume":"21","author":"H Ren","year":"2021","unstructured":"Ren H, et al. CircCCDC66 promotes thyroid cancer cell proliferation, migratory and invasive abilities and glycolysis through the miR-211-5p\/PDK4 axis. Oncol Lett. 2021;21(5):416.","journal-title":"Oncol Lett"},{"issue":"2","key":"2470_CR93","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s13258-020-01023-6","volume":"43","author":"Y Li","year":"2021","unstructured":"Li Y, et al. Knockdown of circPUM1 impedes cell growth, metastasis and glycolysis of papillary thyroid cancer via enhancing MAPK1 expression by serving as the sponge of miR-21-5p. Genes Genomics. 2021;43(2):141\u201350.","journal-title":"Genes Genomics"},{"issue":"8","key":"2470_CR94","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.21037\/gs-21-481","volume":"10","author":"W Chen","year":"2021","unstructured":"Chen W, et al. Upregulated circRAD18 promotes tumor progression by reprogramming glucose metabolism in papillary thyroid cancer. Gland Surg. 2021;10(8):2500\u201310.","journal-title":"Gland Surg"},{"issue":"1","key":"2470_CR95","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1186\/s12885-024-12199-5","volume":"24","author":"J Shen","year":"2024","unstructured":"Shen J, et al. Circphgdh downregulation decreases papillary thyroid cancer progression through miR-122-5p\/PKM2 axis. BMC Cancer. 2024;24(1):511.","journal-title":"BMC Cancer"},{"issue":"6","key":"2470_CR96","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1111\/cas.15772","volume":"114","author":"X Ji","year":"2023","unstructured":"Ji X, et al. ALKBH5-induced circular RNA NRIP1 promotes glycolysis in thyroid cancer cells by targeting PKM2. Cancer Sci. 2023;114(6):2318\u201334.","journal-title":"Cancer Sci"},{"issue":"3","key":"2470_CR97","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2147\/vhrm.2006.2.3.213","volume":"2","author":"N Nishida","year":"2006","unstructured":"Nishida N, et al. Angiogenesis in cancer. Vasc Health Risk Manag. 2006;2(3):213\u20139.","journal-title":"Vasc Health Risk Manag"},{"issue":"7347","key":"2470_CR98","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature10144","volume":"473","author":"P Carmeliet","year":"2011","unstructured":"Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature. 2011;473(7347):298\u2013307.","journal-title":"Nature"},{"issue":"3","key":"2470_CR99","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.cell.2013.06.037","volume":"154","author":"K De Bock","year":"2013","unstructured":"De Bock K, et al. Role of PFKFB3-driven glycolysis in vessel sprouting. Cell. 2013;154(3):651\u201363.","journal-title":"Cell"},{"issue":"2","key":"2470_CR100","doi-asserted-by":"publisher","first-page":"11795","DOI":"10.1080\/21655979.2021.2008639","volume":"12","author":"L Zeng","year":"2021","unstructured":"Zeng L, et al. Circular RNA Pvt1 oncogene (CircPVT1) promotes the progression of papillary thyroid carcinoma by activating the Wnt\/\u03b2-catenin signaling pathway and modulating the ratio of microRNA-195 (miR-195) to vascular endothelial growth factor A (VEGFA) expression. Bioengineered. 2021;12(2):11795\u2013810.","journal-title":"Bioengineered"},{"issue":"12","key":"2470_CR101","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1248\/bpb.34.1785","volume":"34","author":"S Takahashi","year":"2011","unstructured":"Takahashi S. Vascular endothelial growth factor (VEGF), VEGF receptors and their inhibitors for antiangiogenic tumor therapy. Biol Pharm Bull. 2011;34(12):1785\u20138.","journal-title":"Biol Pharm Bull"},{"key":"2470_CR102","doi-asserted-by":"publisher","first-page":"p4933194","DOI":"10.1155\/2021\/4933194","volume":"2021","author":"J Liu","year":"2021","unstructured":"Liu J, et al. MiR-126-HMGB1-HIF-1 axis regulates endothelial cell inflammation during exposure to Hypoxia-Acidosis. Dis Markers. 2021;2021:p4933194.","journal-title":"Dis Markers"},{"key":"2470_CR103","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.humpath.2015.12.018","volume":"51","author":"A Salajegheh","year":"2016","unstructured":"Salajegheh A, et al. Interactive role of miR-126 on VEGF-A and progression of papillary and undifferentiated thyroid carcinoma. Hum Pathol. 2016;51:75\u201385.","journal-title":"Hum Pathol"},{"issue":"5","key":"2470_CR104","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1530\/ERC-19-0008","volume":"26","author":"F Wu","year":"2019","unstructured":"Wu F, et al. Exosomes increased angiogenesis in papillary thyroid cancer microenvironment. Endocr Relat Cancer. 2019;26(5):525\u201338.","journal-title":"Endocr Relat Cancer"},{"issue":"15","key":"2470_CR105","first-page":"6570","volume":"23","author":"Y Du","year":"2019","unstructured":"Du Y, et al. Mir-548c-3p suppressed the progression of papillary thyroid carcinoma via inhibition of the HIF1\u03b1-mediated VEGF signaling pathway. Eur Rev Med Pharmacol Sci. 2019;23(15):6570\u20138.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"6","key":"2470_CR106","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1089\/thy.2022.0704","volume":"33","author":"ML Gild","year":"2023","unstructured":"Gild ML, et al. Challenges and strategies to combat resistance mechanisms in thyroid cancer therapeutics. Thyroid. 2023;33(6):682\u201390.","journal-title":"Thyroid"},{"key":"2470_CR107","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.cytogfr.2023.05.001","volume":"73","author":"B Pol\u00f3nia","year":"2023","unstructured":"Pol\u00f3nia B, et al. The role of extracellular vesicles in glycolytic and lipid metabolic reprogramming of cancer cells: consequences for drug resistance. Cytokine Growth Factor Rev. 2023;73:150\u201362.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"10","key":"2470_CR108","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.molmed.2015.08.002","volume":"21","author":"D Sousa","year":"2015","unstructured":"Sousa D, Lima RT, Vasconcelos MH. Intercellular transfer of cancer drug resistance traits by extracellular vesicles. Trends Mol Med. 2015;21(10):595\u2013608.","journal-title":"Trends Mol Med"},{"issue":"11","key":"2470_CR109","doi-asserted-by":"publisher","first-page":"10773","DOI":"10.1007\/s13277-014-2377-z","volume":"35","author":"MM Lv","year":"2014","unstructured":"Lv MM, et al. Exosomes mediate drug resistance transfer in MCF-7 breast cancer cells and a probable mechanism is delivery of P-glycoprotein. Tumor Biol. 2014;35(11):10773\u20139.","journal-title":"Tumor Biol"},{"issue":"10","key":"2470_CR110","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1158\/1541-7786.MCR-13-0636","volume":"12","author":"K Takahashi","year":"2014","unstructured":"Takahashi K, et al. Involvement of extracellular vesicle long noncoding RNA (linc-VLDLR) in tumor cell responses to chemotherapy. Mol Cancer Res. 2014;12(10):1377\u201387.","journal-title":"Mol Cancer Res"},{"issue":"49","key":"2470_CR111","doi-asserted-by":"publisher","first-page":"34211","DOI":"10.1074\/jbc.M109.041152","volume":"284","author":"I Parolini","year":"2009","unstructured":"Parolini I, et al. Microenvironmental pH is a key factor for exosome traffic in tumor cells. J Biol Chem. 2009;284(49):34211\u201322.","journal-title":"J Biol Chem"},{"issue":"6","key":"2470_CR112","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1507\/endocrj.EJ20-0726","volume":"68","author":"Y Liu","year":"2021","unstructured":"Liu Y, et al. Silencing circRNA protein kinase C Iota (circ-PRKCI) suppresses cell progression and glycolysis of human papillary thyroid cancer through circ-PRKCI\/miR-335\/E2F3 CeRNA axis. Endocr J. 2021;68(6):713\u201327.","journal-title":"Endocr J"},{"key":"2470_CR113","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2020.108353","volume":"685","author":"Z Hu","year":"2020","unstructured":"Hu Z, et al. Hsa_circ_0011290 regulates proliferation, apoptosis and glycolytic phenotype in papillary thyroid cancer via miR-1252\/ FSTL1 signal pathway. Arch Biochem Biophys. 2020;685:108353.","journal-title":"Arch Biochem Biophys"},{"issue":"12","key":"2470_CR114","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1136\/gutjnl-2021-325150","volume":"71","author":"J Rao","year":"2022","unstructured":"Rao J, et al. FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2. Gut. 2022;71(12):2539\u201350.","journal-title":"Gut"},{"issue":"2","key":"2470_CR115","doi-asserted-by":"publisher","first-page":"277","DOI":"10.20517\/cdr.2021.134","volume":"5","author":"T Koltai","year":"2022","unstructured":"Koltai T. The complex relationship between multiple drug resistance and the tumor pH gradient: a review. Cancer Drug Resist. 2022;5(2):277\u2013303.","journal-title":"Cancer Drug Resist"},{"key":"2470_CR116","doi-asserted-by":"crossref","unstructured":"Komatsuda H et al. Harnessing immunity to treat advanced thyroid cancer. Vaccines. 2024;12(1):45.","DOI":"10.3390\/vaccines12010045"},{"key":"2470_CR117","doi-asserted-by":"publisher","DOI":"10.3390\/cells11121946","author":"QH Xie","year":"2022","unstructured":"Xie QH, et al. Exosome-mediated immunosuppression in tumor microenvironments. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11121946.","journal-title":"Cells"},{"issue":"1","key":"2470_CR118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molmed.2015.11.003","volume":"22","author":"D Wang","year":"2016","unstructured":"Wang D, DuBois RN. The role of prostaglandin E2 in tumor-associated immunosuppression. Trends Mol Med. 2016;22(1):1\u20133.","journal-title":"Trends Mol Med"},{"issue":"1","key":"2470_CR119","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00801-2","volume":"6","author":"Y Wei","year":"2021","unstructured":"Wei Y, et al. An RNA-RNA crosstalk network involving HMGB1 and RICTOR facilitates hepatocellular carcinoma tumorigenesis by promoting glutamine metabolism and impedes immunotherapy by PD-L1\u2009+\u2009exosomes activity. Signal Transduct Target Ther. 2021;6(1):421.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2470_CR120","doi-asserted-by":"publisher","first-page":"e2200161","DOI":"10.1002\/adbi.202200161","volume":"7","author":"B Li","year":"2023","unstructured":"Li B, et al. Macrophages in tumor-Associated adipose microenvironment accelerate tumor progression. Adv Biol (Weinh). 2023;7(1):e2200161.","journal-title":"Adv Biol (Weinh)"},{"key":"2470_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2021.105279","volume":"117","author":"A Burassakarn","year":"2021","unstructured":"Burassakarn A, et al. Exosomes-carrying Epstein-Barr virus-encoded small RNA-1 induces indoleamine 2, 3-dioxygenase expression in tumor-infiltrating macrophages of oral squamous-cell carcinomas and suppresses T-cell activity by activating RIG-I\/IL-6\/TNF-\u03b1 pathway. Oral Oncol. 2021;117:105279.","journal-title":"Oral Oncol"},{"issue":"4","key":"2470_CR122","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1080\/10799893.2017.1298131","volume":"37","author":"J Wang","year":"2017","unstructured":"Wang J, et al. High glucose induces alternative activation of macrophages via PI3K\/Akt signaling pathway. J Recept Signal Transduct Res. 2017;37(4):409\u201315.","journal-title":"J Recept Signal Transduct Res"},{"key":"2470_CR123","doi-asserted-by":"publisher","DOI":"10.1007\/s10528-024-10747-z","author":"SB Liu","year":"2024","unstructured":"Liu SB. MiR-374a\/b-5p suppresses cell growth in papillary thyroid carcinoma through blocking exosomal ANXA1-induced macrophage M2 polarization. Biochem Genet. 2024. https:\/\/doi.org\/10.1007\/s10528-024-10747-z.","journal-title":"Biochem Genet"},{"key":"2470_CR124","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20184413","author":"SM Ferrari","year":"2019","unstructured":"Ferrari SM, et al. Immune and inflammatory cells in thyroid cancer microenvironment. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20184413.","journal-title":"Int J Mol Sci"},{"issue":"18","key":"2470_CR125","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","volume":"79","author":"DC Hinshaw","year":"2019","unstructured":"Hinshaw DC, Shevde LA. The tumor microenvironment innately modulates cancer progression. Cancer Res. 2019;79(18):4557\u201366.","journal-title":"Cancer Res"},{"issue":"7","key":"2470_CR126","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1158\/1541-7786.MCR-17-0784","volume":"16","author":"CR Goulet","year":"2018","unstructured":"Goulet CR, et al. Exosomes induce fibroblast differentiation into cancer-associated fibroblasts through TGF\u03b2 signaling. Mol Cancer Res. 2018;16(7):1196\u2013204.","journal-title":"Mol Cancer Res"},{"issue":"12","key":"2470_CR127","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41571-021-00546-5","volume":"18","author":"Y Chen","year":"2021","unstructured":"Chen Y, McAndrews KM, Kalluri R. Clinical and therapeutic relevance of cancer-associated fibroblasts. Nat Rev Clin Oncol. 2021;18(12):792\u2013804.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"2470_CR128","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13046-020-01611-0","volume":"39","author":"GJ Yoshida","year":"2020","unstructured":"Yoshida GJ. Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways. J Exp Clin Cancer Res. 2020;39(1):112.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"2470_CR129","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12943-021-01463-y","volume":"20","author":"C Li","year":"2021","unstructured":"Li C, et al. Cancer associated-fibroblast-derived exosomes in cancer progression. Mol Cancer. 2021;20(1):154.","journal-title":"Mol Cancer"},{"issue":"1","key":"2470_CR130","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13045-022-01359-4","volume":"15","author":"T Liu","year":"2022","unstructured":"Liu T, et al. Cancer-associated fibroblast-specific lncRNA LINC01614 enhances glutamine uptake in lung adenocarcinoma. J Hematol Oncol. 2022;15(1):141.","journal-title":"J Hematol Oncol"},{"key":"2470_CR131","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.10250","author":"HY Zhao","year":"2016","unstructured":"Zhao HY, et al. Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism. Elife. 2016. https:\/\/doi.org\/10.7554\/eLife.10250.","journal-title":"Elife"},{"issue":"1","key":"2470_CR132","doi-asserted-by":"publisher","first-page":"8028","DOI":"10.1038\/s41598-019-44361-6","volume":"9","author":"L Fozzatti","year":"2019","unstructured":"Fozzatti L, et al. Interplay of fibroblasts with anaplastic tumor cells promotes follicular thyroid cancer progression. Sci Rep. 2019;9(1):8028.","journal-title":"Sci Rep"},{"key":"2470_CR133","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.canlet.2020.03.004","volume":"478","author":"X Wu","year":"2020","unstructured":"Wu X, et al. Extracellular vesicle packaged LMP1-activated fibroblasts promote tumor progression via autophagy and stroma-tumor metabolism coupling. Cancer Lett. 2020;478:93\u2013106.","journal-title":"Cancer Lett"},{"issue":"5","key":"2470_CR134","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41556-018-0083-6","volume":"20","author":"W Yan","year":"2018","unstructured":"Yan W, et al. Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells. Nat Cell Biol. 2018;20(5):597\u2013609.","journal-title":"Nat Cell Biol"},{"issue":"7","key":"2470_CR135","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.7150\/thno.94207","volume":"14","author":"X Jin","year":"2024","unstructured":"Jin X, et al. Cancer-associated fibroblast-derived periostin promotes papillary thyroid tumor growth through integrin-FAK-STAT3 signaling. Theranostics. 2024;14(7):3014\u201328.","journal-title":"Theranostics"},{"key":"2470_CR136","doi-asserted-by":"publisher","DOI":"10.3892\/or.2024.8716","author":"Y Yang","year":"2024","unstructured":"Yang Y, et al. Effect of hypoxia\u2013HIF\u20131\u03b1\u2013periostin axis in thyroid cancer. Oncol Rep. 2024. https:\/\/doi.org\/10.3892\/or.2024.8716.","journal-title":"Oncol Rep"},{"issue":"3","key":"2470_CR137","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jcrpr.2017.03.003","volume":"4","author":"C-Y Kuo","year":"2017","unstructured":"Kuo C-Y, et al. Characteristics of lymphocyte-infiltrating papillary thyroid cancer. Journal of Cancer Research and Practice. 2017;4(3):95\u20139.","journal-title":"Journal of Cancer Research and Practice"},{"issue":"5","key":"2470_CR138","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1210\/jc.2009-2564","volume":"95","author":"JD French","year":"2010","unstructured":"French JD, et al. Tumor-associated lymphocytes and increased FoxP3\u2009+\u2009regulatory T cell frequency correlate with more aggressive papillary thyroid cancer. J Clin Endocrinol Metab. 2010;95(5):2325\u201333.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1\u20132","key":"2470_CR139","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1159\/000452541","volume":"40","author":"C Li","year":"2016","unstructured":"Li C, et al. Imbalance of Th17\/Treg in different subtypes of autoimmune thyroid diseases. Cell Physiol Biochem. 2016;40(1\u20132):245\u201352.","journal-title":"Cell Physiol Biochem"},{"issue":"9","key":"2470_CR140","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.1172\/JCI80011","volume":"125","author":"L Chen","year":"2015","unstructured":"Chen L, Han X. Anti-PD-1\/PD-L1 therapy of human cancer: past, present, and future. J Clin Invest. 2015;125(9):3384\u201391.","journal-title":"J Clin Invest"},{"issue":"2","key":"2470_CR141","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.yexcr.2019.01.021","volume":"376","author":"X Wang","year":"2019","unstructured":"Wang X, et al. IL-10-producing B cells in differentiated thyroid cancer suppress the effector function of T cells but improve their survival upon activation. Exp Cell Res. 2019;376(2):192\u20137.","journal-title":"Exp Cell Res"},{"issue":"12","key":"2470_CR142","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1089\/thy.2012.0560","volume":"23","author":"F Gogali","year":"2013","unstructured":"Gogali F, et al. CD3(-)CD16(-)CD56(bright) immunoregulatory NK cells are increased in the tumor microenvironment and inversely correlate with advanced stages in patients with papillary thyroid cancer. Thyroid. 2013;23(12):1561\u20138.","journal-title":"Thyroid"},{"issue":"6","key":"2470_CR143","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1210\/clinem\/dgad725","volume":"109","author":"G Li","year":"2024","unstructured":"Li G, et al. Exosome-mediated delivery of miR-519e-5p promotes malignant tumor phenotype and CD8\u2009+\u2009T-cell exhaustion in metastatic PTC. J Clin Endocrinol Metab. 2024;109(6):1601\u201317.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2470_CR144","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/nm.3615","volume":"20","author":"P Bi","year":"2014","unstructured":"Bi P, et al. Inhibition of notch signaling promotes browning of white adipose tissue and ameliorates obesity. Nat Med. 2014;20(8):911\u20138.","journal-title":"Nat Med"},{"key":"2470_CR145","doi-asserted-by":"publisher","first-page":"39117","DOI":"10.1038\/srep39117","volume":"6","author":"M Coutaz","year":"2016","unstructured":"Coutaz M, et al. Notch regulates Th17 differentiation and controls trafficking of IL-17 and metabolic regulators within Th17 cells in a context-dependent manner. Sci Rep. 2016;6:39117.","journal-title":"Sci Rep"},{"issue":"11","key":"2470_CR146","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113424","volume":"42","author":"F Xu","year":"2023","unstructured":"Xu F, et al. Prostate cancer cell-derived exosomal IL-8 fosters immune evasion by disturbing glucolipid metabolism of CD8(+) T cell. Cell Rep. 2023;42(11):113424.","journal-title":"Cell Rep"},{"key":"2470_CR147","doi-asserted-by":"crossref","unstructured":"Cui XJ et al. Thyrocyte-derived exosome-targeted dendritic cells stimulate strong CD4\u2009<\u2009SUP>+\u2009T lymphocyte responses. Mol Cell Endocrinol. 2020;506:110756.","DOI":"10.1016\/j.mce.2020.110756"},{"issue":"5","key":"2470_CR148","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/bjh.16569","volume":"190","author":"X Wu","year":"2020","unstructured":"Wu X, et al. The 60-kDa heat shock protein regulates energy rearrangement and protein synthesis to promote proliferation of multiple myeloma cells. Br J Haematol. 2020;190(5):741\u201352.","journal-title":"Br J Haematol"},{"key":"2470_CR149","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22084196","author":"L Paladino","year":"2021","unstructured":"Paladino L, et al. Molecular chaperones and thyroid cancer. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22084196.","journal-title":"Int J Mol Sci"},{"key":"2470_CR150","doi-asserted-by":"publisher","first-page":"20176","DOI":"10.1038\/srep20176","volume":"6","author":"W Ying","year":"2016","unstructured":"Ying W, et al. Mir-150 regulates obesity-associated insulin resistance by controlling B cell functions. Sci Rep. 2016;6:20176.","journal-title":"Sci Rep"},{"issue":"1","key":"2470_CR151","doi-asserted-by":"publisher","first-page":"27","DOI":"10.5603\/ep.98120","volume":"75","author":"L Cheng","year":"2024","unstructured":"Cheng L, Deng X, Le Y. MYB\/LINC00092 regulatory axis promotes the progression of papillary thyroid carcinoma. Endokrynol Pol. 2024;75(1):27\u201334.","journal-title":"Endokrynol Pol"},{"issue":"4","key":"2470_CR152","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.4049\/jimmunol.1500516","volume":"196","author":"BC King","year":"2016","unstructured":"King BC, et al. CD46 activation regulates miR-150-mediated control of GLUT1 expression and cytokine secretion in human CD4\u2009+\u2009T cells. J Immunol. 2016;196(4):1636\u201345.","journal-title":"J Immunol"},{"issue":"1","key":"2470_CR153","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00805-y","volume":"6","author":"Y Wang","year":"2021","unstructured":"Wang Y, et al. Natural killer cell-derived exosomal miR-1249-3p attenuates insulin resistance and inflammation in mouse models of type 2 diabetes. Signal Transduct Target Ther. 2021;6(1):409.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"2470_CR154","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1189\/jlb.0611308","volume":"91","author":"R Wang","year":"2012","unstructured":"Wang R, et al. Natural killer cell-produced IFN-\u03b3 and TNF-\u03b1 induce target cell cytolysis through up-regulation of ICAM-1. J Leukoc Biol. 2012;91(2):299\u2013309.","journal-title":"J Leukoc Biol"},{"issue":"1","key":"2470_CR155","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12943-021-01492-7","volume":"21","author":"R Hosseini","year":"2022","unstructured":"Hosseini R, et al. Cancer exosomes and natural killer cells dysfunction: biological roles, clinical significance and implications for immunotherapy. Mol Cancer. 2022;21(1):15.","journal-title":"Mol Cancer"},{"key":"2470_CR156","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11060874","author":"J Zhao","year":"2019","unstructured":"Zhao J, et al. Tumor-derived extracellular vesicles inhibit natural killer cell function in pancreatic cancer. Cancers (Basel). 2019. https:\/\/doi.org\/10.3390\/cancers11060874.","journal-title":"Cancers (Basel)"},{"issue":"415","key":"2470_CR157","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aad1884","volume":"9","author":"S Viel","year":"2016","unstructured":"Viel S, et al. TGF-\u03b2 inhibits the activation and functions of NK cells by repressing the mTOR pathway. Sci Signal. 2016;9(415):ra19.","journal-title":"Sci Signal"},{"issue":"12","key":"2470_CR158","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.it.2016.09.006","volume":"37","author":"A Gardner","year":"2016","unstructured":"Gardner A, Ruffell B. Dendritic cells and cancer immunity. Trends Immunol. 2016;37(12):855\u201365.","journal-title":"Trends Immunol"},{"key":"2470_CR159","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.coi.2017.01.002","volume":"45","author":"F Veglia","year":"2017","unstructured":"Veglia F, Gabrilovich DI. Dendritic cells in cancer: the role revisited. Curr Opin Immunol. 2017;45:43\u201351.","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"2470_CR160","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","volume":"20","author":"SK Wculek","year":"2020","unstructured":"Wculek SK, et al. Dendritic cells in cancer immunology and immunotherapy. Nat Rev Immunol. 2020;20(1):7\u201324.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"2470_CR161","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.semcancer.2012.01.011","volume":"22","author":"S Ostrand-Rosenberg","year":"2012","unstructured":"Ostrand-Rosenberg S, et al. Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression. Semin Cancer Biol. 2012;22(4):275\u201381.","journal-title":"Semin Cancer Biol"},{"key":"2470_CR162","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2020.110756","volume":"506","author":"X Cui","year":"2020","unstructured":"Cui X, et al. Thyrocyte-derived exosome-targeted dendritic cells stimulate strong CD4\u2009+\u2009t lymphocyte responses. Mol Cell Endocrinol. 2020;506:110756.","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"2470_CR163","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108278","volume":"33","author":"X Yin","year":"2020","unstructured":"Yin X, et al. Ppar\u03b1 inhibition overcomes tumor-derived exosomal lipid-induced dendritic cell dysfunction. Cell Rep. 2020;33(3):108278.","journal-title":"Cell Rep"},{"issue":"8","key":"2470_CR164","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/nm.2172","volume":"16","author":"DL Herber","year":"2010","unstructured":"Herber DL, et al. Lipid accumulation and dendritic cell dysfunction in cancer. Nat Med. 2010;16(8):880\u20136.","journal-title":"Nat Med"},{"issue":"2","key":"2470_CR165","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s12094-021-02682-x","volume":"24","author":"MH Wang","year":"2022","unstructured":"Wang MH, et al. Exosome-mediated delivery of SCD-1 siRNA promoted the death of anaplastic thyroid carcinoma cells via regulating ROS level. Clin Transl Oncol. 2022;24(2):288\u201396.","journal-title":"Clin Transl Oncol"},{"issue":"8","key":"2470_CR166","first-page":"883","volume":"10","author":"LM Paardekooper","year":"2019","unstructured":"Paardekooper LM, Vos W, van den Bogaart G. Oxygen Tumor Microenvironment: Eff Dendritic Cell Function Oncotarget. 2019;10(8):883\u201396.","journal-title":"Oxygen Tumor Microenvironment: Eff Dendritic Cell Function Oncotarget"},{"issue":"4","key":"2470_CR167","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s40618-022-01921-4","volume":"46","author":"H Zhang","year":"2023","unstructured":"Zhang H, et al. Circ_0002111\/miR-134-5p\/FSTL1 signal axis regulates tumor progression and glycolytic metabolism in papillary thyroid carcinoma cells. J Endocrinol Invest. 2023;46(4):713\u201325.","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"2470_CR168","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.4049\/jimmunol.1202702","volume":"191","author":"Z Husain","year":"2013","unstructured":"Husain Z, et al. Tumor-derived lactate modifies antitumor immune response: effect on myeloid-derived suppressor cells and NK cells. J Immunol. 2013;191(3):1486\u201395.","journal-title":"J Immunol"},{"key":"2470_CR169","doi-asserted-by":"publisher","first-page":"155832","DOI":"10.1016\/j.metabol.2024.155832","volume":"155","author":"S Xu","year":"2024","unstructured":"Xu S, et al. Interleukin-6 classic and trans-signaling utilize glucose metabolism reprogramming to achieve anti- or pro-inflammatory effects. Metabolism. 2024;155:155832.","journal-title":"Metabolism"},{"issue":"1","key":"2470_CR170","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13578-022-00823-5","volume":"12","author":"M Li","year":"2022","unstructured":"Li M, et al. Targeting tumor-associated macrophages for cancer treatment. Cell Biosci. 2022;12(1):85.","journal-title":"Cell Biosci"},{"issue":"12","key":"2470_CR171","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.1007\/s00262-023-03549-6","volume":"72","author":"L Zhu","year":"2023","unstructured":"Zhu L, et al. Tumor-associated macrophages as a potential therapeutic target in thyroid cancers. Cancer Immunol Immunother. 2023;72(12):3895\u2013917.","journal-title":"Cancer Immunol Immunother"},{"issue":"5","key":"2470_CR172","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s00011-020-01318-0","volume":"69","author":"MS Baig","year":"2020","unstructured":"Baig MS, et al. Tumor-derived exosomes in the regulation of macrophage polarization. Inflamm Res. 2020;69(5):435\u201351.","journal-title":"Inflamm Res"},{"issue":"10","key":"2470_CR173","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1038\/s41418-023-01217-x","volume":"30","author":"J Ning","year":"2023","unstructured":"Ning J, et al. METTL3 inhibition induced by M2 macrophage-derived extracellular vesicles drives anti-PD-1 therapy resistance via M6A-CD70-mediated immune suppression in thyroid cancer. Cell Death Differ. 2023;30(10):2265\u201379.","journal-title":"Cell Death Differ"},{"issue":"2","key":"2470_CR174","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1210\/clinem\/dgab480","volume":"107","author":"S Lin","year":"2021","unstructured":"Lin S, et al. METTL3-induced miR-222-3p upregulation inhibits STK4 and promotes the malignant behaviors of thyroid carcinoma cells. J Clin Endocrinol Metab. 2021;107(2):474\u201390.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2470_CR175","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1210\/en.2018-00898","volume":"160","author":"CM Pombo","year":"2019","unstructured":"Pombo CM, et al. MST kinases and metabolism. Endocrinology. 2019;160(5):1111\u20138.","journal-title":"Endocrinology"},{"issue":"10","key":"2470_CR176","doi-asserted-by":"publisher","first-page":"8511","DOI":"10.18632\/aging.205811","volume":"16","author":"XY Zhao","year":"2024","unstructured":"Zhao XY, et al. LncRNA SH3BP5-AS1 promotes hepatocellular carcinoma progression by sponging miR-6838-5p and activation of PTPN4. Aging. 2024;16(10):8511\u201323.","journal-title":"Aging"},{"issue":"3","key":"2470_CR177","first-page":"1463","volume":"37","author":"B Liu","year":"2023","unstructured":"Liu B, et al. Tumor-Derived Exosomal LncRNA\u2009<\u2009i\u2009>\u2009FGD5-AS1\u2009Promotes migration and invasion of thyroid cancer cells SW1736 by inducing macrophage M2 polarization. J Biol Regul Homeost Agents. 2023;37(3):1463\u201372.","journal-title":"J Biol Regul Homeost Agents"},{"key":"2470_CR178","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23115","author":"DY Huang","year":"2022","unstructured":"Huang DY, et al. Cdc42 promotes thyroid cancer cell proliferation and migration and tumor-associated macrophage polarization through the PTEN\/AKT pathway. J Biochem Mol Toxicol. 2022. https:\/\/doi.org\/10.1002\/jbt.23115.","journal-title":"J Biochem Mol Toxicol"},{"key":"2470_CR179","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.103016","author":"YY Zhang","year":"2024","unstructured":"Zhang YY, et al. M2 macrophage exosome-derived LncRNA AK083884 protects mice from CVB3-induced viral myocarditis through regulating PKM2\/HIF-1\u03b1 axis mediated metabolic reprogramming of macrophages. Redox Biol. 2024. https:\/\/doi.org\/10.1016\/j.redox.2023.103016.","journal-title":"Redox Biol"},{"issue":"21","key":"2470_CR180","doi-asserted-by":"publisher","first-page":"8874","DOI":"10.1158\/0008-5472.CAN-10-1994","volume":"70","author":"M Todaro","year":"2010","unstructured":"Todaro M, et al. Tumorigenic and metastatic activity of human thyroid cancer stem cells. Cancer Res. 2010;70(21):8874\u201385.","journal-title":"Cancer Res"},{"issue":"5","key":"2470_CR181","doi-asserted-by":"publisher","first-page":"T285","DOI":"10.1530\/ERC-14-0002","volume":"21","author":"Z Guo","year":"2014","unstructured":"Guo Z, Hardin H, Lloyd RV. Cancer stem-like cells and thyroid cancer. Endocr Relat Cancer. 2014;21(5):T285\u2013300.","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"2470_CR182","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s00268-017-4331-x","volume":"42","author":"K Mahkamova","year":"2018","unstructured":"Mahkamova K, et al. Hypoxia increases thyroid cancer stem cell-enriched side population. World J Surg. 2018;42(2):350\u20137.","journal-title":"World J Surg"},{"issue":"2","key":"2470_CR183","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.yexcr.2018.07.036","volume":"370","author":"M Shimamura","year":"2018","unstructured":"Shimamura M, et al. Intracellular redox status controls spherogenicity, an in vitro cancer stem cell marker, in thyroid cancer cell lines. Exp Cell Res. 2018;370(2):699\u2013707.","journal-title":"Exp Cell Res"},{"key":"2470_CR184","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biochi.2023.03.014","volume":"212","author":"K Rashid","year":"2023","unstructured":"Rashid K, et al. Cancer stem cell-derived exosome-induced metastatic cancer: an orchestra within the tumor microenvironment. Biochimie. 2023;212:1\u201311.","journal-title":"Biochimie"},{"key":"2470_CR185","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae667","author":"S Moretti","year":"2024","unstructured":"Moretti S, et al. Wnt\/B-catenin activation and TP53 mutations associate with distinct immune profiles in advanced thyroid cancer. J Clin Endocrinol Metab. 2024. https:\/\/doi.org\/10.1210\/clinem\/dgae667.","journal-title":"J Clin Endocrinol Metab"},{"issue":"35","key":"2470_CR186","doi-asserted-by":"publisher","first-page":"29406","DOI":"10.1074\/jbc.M112.348946","volume":"287","author":"O Chan","year":"2012","unstructured":"Chan O, et al. The chemokine CCL5 regulates glucose uptake and AMP kinase signaling in activated T cells to facilitate chemotaxis. J Biol Chem. 2012;287(35):29406\u201316.","journal-title":"J Biol Chem"},{"issue":"9","key":"2470_CR187","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/s41374-018-0065-0","volume":"98","author":"H Hardin","year":"2018","unstructured":"Hardin H, et al. Thyroid cancer stem-like cell exosomes: regulation of EMT via transfer of LncRNAs. Lab Invest. 2018;98(9):1133\u201342.","journal-title":"Lab Invest"},{"issue":"12","key":"2470_CR188","doi-asserted-by":"publisher","first-page":"4821","DOI":"10.1002\/jcb.26153","volume":"118","author":"JK Huang","year":"2017","unstructured":"Huang JK, et al. LncRNA-MALAT1 promotes angiogenesis of thyroid cancer by modulating tumor-associated macrophage FGF2 protein secretion. J Cell Biochem. 2017;118(12):4821\u201330.","journal-title":"J Cell Biochem"},{"key":"2470_CR189","doi-asserted-by":"crossref","unstructured":"Wang ZX, et al. IL-10 enhances human natural killer cell effector functions via metabolic reprogramming regulated by mTORC1 signaling. Frontiers in Immunology; 2021. p. 12.","DOI":"10.3389\/fimmu.2021.619195"},{"issue":"7","key":"2470_CR190","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.7150\/thno.52570","volume":"11","author":"Y Liang","year":"2021","unstructured":"Liang Y, et al. Engineering exosomes for targeted drug delivery. Theranostics. 2021;11(7):3183\u201395.","journal-title":"Theranostics"},{"issue":"1","key":"2470_CR191","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12967-021-02768-8","volume":"19","author":"MJ Gonzalez","year":"2021","unstructured":"Gonzalez MJ, et al. Evaluation of exosome derivatives as bio-informational reprogramming therapy for cancer. J Transl Med. 2021;19(1):103.","journal-title":"J Transl Med"},{"key":"2470_CR192","doi-asserted-by":"publisher","DOI":"10.3390\/metabo12121214","author":"Y Nagayama","year":"2022","unstructured":"Nagayama Y, Hamada K. Reprogramming of cellular metabolism and its therapeutic applications in thyroid cancer. Metabolites. 2022. https:\/\/doi.org\/10.3390\/metabo12121214.","journal-title":"Metabolites"},{"key":"2470_CR193","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.imlet.2022.04.004","volume":"246","author":"L Chen","year":"2022","unstructured":"Chen L, Zhuo D, Yuan H. Circ_100395 impedes malignancy and glycolysis in papillary thyroid cancer: involvement of PI3K\/AKT\/mTOR signaling pathway. Immunol Lett. 2022;246:10\u20137.","journal-title":"Immunol Lett"},{"issue":"7","key":"2470_CR194","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1089\/hum.2018.160","volume":"30","author":"Y Miao","year":"2019","unstructured":"Miao Y, et al. Therapeutic delivery of miR-143 targeting tumor metabolism in poorly differentiated thyroid cancer xenografts and efficacy evaluation using (18)F-FDG microPET-CT. Hum Gene Ther. 2019;30(7):882\u201392.","journal-title":"Hum Gene Ther"},{"issue":"1","key":"2470_CR195","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-31323-7","volume":"8","author":"S Shu","year":"2018","unstructured":"Shu S, et al. Metabolic reprogramming of stromal fibroblasts by melanoma exosome microRNA favours a pre-metastatic microenvironment. Sci Rep. 2018;8(1):12905.","journal-title":"Sci Rep"},{"issue":"11","key":"2470_CR196","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1093\/neuonc\/noac071","volume":"24","author":"Q Zhan","year":"2022","unstructured":"Zhan Q, et al. Blood exosomes-based targeted delivery of cPLA2 siRNA and metformin to modulate glioblastoma energy metabolism for tailoring personalized therapy. Neuro Oncol. 2022;24(11):1871\u201383.","journal-title":"Neuro Oncol"},{"key":"2470_CR197","doi-asserted-by":"publisher","first-page":"121462","DOI":"10.1016\/j.biomaterials.2022.121462","volume":"283","author":"D Zhu","year":"2022","unstructured":"Zhu D, et al. Tumor-derived exosomes co-delivering aggregation-induced emission luminogens and proton pump inhibitors for tumor glutamine starvation therapy and enhanced type-I photodynamic therapy. Biomaterials. 2022;283:121462.","journal-title":"Biomaterials"},{"issue":"17","key":"2470_CR198","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202105376","volume":"9","author":"L Wu","year":"2022","unstructured":"Wu L, et al. Biomimetic nanocarriers guide extracellular ATP homeostasis to remodel energy metabolism for activating innate and adaptive immunity system. Adv Sci (Weinh). 2022;9(17):e2105376.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"2470_CR199","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01654-2","volume":"22","author":"M Shi","year":"2024","unstructured":"Shi M, et al. Tumor derived exosomal ENTPD2 impair CD8(+) T cell function in colon cancer through ATP-adenosine metabolism reprogramming. Cell Commun Signal. 2024;22(1):274.","journal-title":"Cell Commun Signal"},{"issue":"8","key":"2470_CR200","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.7150\/thno.41580","volume":"10","author":"DB Yang","year":"2020","unstructured":"Yang DB, et al. Progress, opportunity, and perspective on exosome isolation - efforts for efficient exosome-based theranostics. Theranostics. 2020;10(8):3684\u2013707.","journal-title":"Theranostics"},{"key":"2470_CR201","doi-asserted-by":"publisher","first-page":"8211","DOI":"10.2147\/IJN.S479533","volume":"19","author":"C Wang","year":"2024","unstructured":"Wang C, Xu S, Yang X. Hypoxia-driven changes in tumor microenvironment: insights into exosome-mediated cell interactions. Int J Nanomed. 2024;19:8211\u201336.","journal-title":"Int J Nanomed"},{"key":"2470_CR202","doi-asserted-by":"publisher","DOI":"10.1007\/s10528-024-10833-2","author":"Y Wang","year":"2024","unstructured":"Wang Y, et al. Exosome-mediated communication in thyroid cancer: implications for prognosis and therapeutic targets. Biochem Genet. 2024. https:\/\/doi.org\/10.1007\/s10528-024-10833-2.","journal-title":"Biochem Genet"},{"key":"2470_CR203","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1146\/annurev-physiol-042222-024535","volume":"86","author":"ERK Cunha","year":"2024","unstructured":"Cunha ERK, Ying W, Olefsky JM. Exosome-Mediated impact on systemic metabolism. Annu Rev Physiol. 2024;86:225\u201353.","journal-title":"Annu Rev Physiol"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02470-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-025-02470-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02470-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T03:31:30Z","timestamp":1759894290000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-025-02470-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":203,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2470"],"URL":"https:\/\/doi.org\/10.1186\/s12943-025-02470-z","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,8]]},"assertion":[{"value":"25 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"247"}}